1van Rooij IA, Broekmans F J, Te Velde ER, et al. Serum anti- Miillerian hormone levels: a novel measure of ovarian reserve. Hum Reprod, 2002, 17(12):3065-71.
2Cook CL, Siow Y, Brenner AG, et al. Relationship between serum MiJllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syn- drome and normal women. Fertil Steril, 2002, 77(1): 141-6.
4Pigny P, Jonard S, Robert Y, et al. Serum anti-Mtillerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab, 2006, 91(3):941-5.
5Wang JG, Nakhuda GS, Guarnaccia MM, et al. Mtillerian inhibiting substance and disrupted folliculogenesis in poly- cystic ovary syndrome. Am J Obstet Gynecol, 2007, 196(1): 77.el-5.
6Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-Mtillerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab, 2003, 88(12): 5957-62.
7Chang HM, Klausen C, Leung PC. Anti Miillerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol pro- duction in human granulosa-lutein cells. Fertil Steril, 2013, 100(2): 585-92.
8The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consen- sus Workshop Group: Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod, 2008, 23(3):462-77.
9Broer SL, Mol BW, Hendriks D, et al. The role of anti- Mtillerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril, 2009, 91(3):705-14.
10Elgindy EA, E1-Haieg DO, E1-Sebaey A. Anti-Miillerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril, 2008, 89(6): 1670-6.
